Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Management of Diabetes during Fasting and Feasting in India.

Saboo B, Joshi S, Shah SN, Tiwaskar M, Vishwanathan V, Bhandari S, Jha S, Chaudhary T, Arvind SR, Chawla R, Kalra S, Hasnani D.

J Assoc Physicians India. 2019 Sep;67(9):70-77.

PMID:
31561693
2.

Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force.

Kalra S, Das AK, Sahay RK, Baruah MP, Tiwaskar M, Das S, Chatterjee S, Saboo B, Bantwal G, Bhattacharya S, Priya G, Chawla M, Brar K, Raza SA, Aamir AH, Shrestha D, Somasundaram N, Katulanda P, Afsana F, Selim S, Naseri MW, Latheef A, Sumanatilleke M.

Diabetes Ther. 2019 Oct;10(5):1645-1717. doi: 10.1007/s13300-019-0669-4. Epub 2019 Jul 29. Review.

PMID:
31359367
3.

Use of Ambulatory Glucose Profile for Improving Monitoring and Management of T2DM.

Saboo B, Sheth SV, Joshi S, Bhandari S, Kesavadev J, Maheshwari A, Agrawal M, Hasnani D, Patel F, Panchal D, Goklani R.

J Assoc Physicians India. 2018 Jul;66(7):69-71.

PMID:
31325267
4.

Expert Group Recommendations on Detection and Management of Hypoglycemia in Routine Clinical Practice in Insulin Treated Patients with Diabetes.

Singh AK, Talwalkar PG, Ahluwalia A, Modi KD, Saboo B.

J Assoc Physicians India. 2018 Dec;66(12):90-97.

PMID:
31313564
5.

Strengthening the Family - the 'Five-I' Approach.

Kalra S, Saboo B, Cho NH, Sadikot S, Hasnani D, Chandarana H, Verma M, Bhandari S, Gupta A, Aravind SR.

Eur Endocrinol. 2019 Apr;15(1):15-16. doi: 10.17925/EE.2019.15.1.15. Epub 2019 Apr 12.

6.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

7.

BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion.

Bajaj S, Das AK, Kalra S, Sahay R, Saboo B, Das S, Shunmugavelu M, Jacob J, Priya G, Khandelwal D, Dutta D, Chawla M, Surana V, Tiwaskar M, Joshi A, Shrestha PK, Bhattarai J, Bhowmik B, Latt TS, Aye TT, Vijayakumar G, Baruah M, Jawad F, Unnikrishnan AG, Chowdhury S, Pathan MF, Somasundaram N, Sumanathilaka M, Raza A, Bahendeka SK, Coetzee A, Ruder S, Ramaiya K, Lamptey R, Bavuma C, Shaikh K, Uloko A, Chaudhary S, Abdela AA, Akanov Z, Rodrìguez-Saldaña J, Faradji R, Tiago A, Reja A, Czupryniak L.

Diabetes Ther. 2019 Aug;10(4):1189-1204. doi: 10.1007/s13300-019-0629-z. Epub 2019 May 17. Review.

8.

Insights on Medical Nutrition Therapy for Type 2 Diabetes Mellitus: An Indian Perspective.

Viswanathan V, Krishnan D, Kalra S, Chawla R, Tiwaskar M, Saboo B, Baruah M, Chowdhury S, Makkar BM, Jaggi S.

Adv Ther. 2019 Mar;36(3):520-547. doi: 10.1007/s12325-019-0872-8. Epub 2019 Feb 7. Review.

PMID:
30729455
9.

Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians.

Singh AK, Unnikrishnan AG, Zargar AH, Kumar A, Das AK, Saboo B, Sinha B, Gangopadhyay KK, Talwalkar PG, Ghosal S, Kalra S, Joshi S, Sharma SK, Sriram U, Mohan V.

Diabetes Ther. 2019 Apr;10(2):393-428. doi: 10.1007/s13300-019-0562-1. Epub 2019 Jan 31. Review.

10.

Recommendations for in-clinic PoCT for diabetes management in India.

Saboo B, Sadikot S, Prasanna Kumar KM, Joshi S, Aravind SR, Makkar BM, Chawla R, Kesavadev J, Chawla M, Kovil R, Shah T, Mohit M, Vyas C, Dhandhania VK.

Diabetes Metab Syndr. 2019 Jan - Feb;13(1):5-7. doi: 10.1016/j.dsx.2018.05.005. Epub 2018 May 8.

PMID:
30641753
11.

Exenatide implant therapy in diabetes.

Kalra S, Saboo B.

J Pak Med Assoc. 2018 Oct;68(10):1538-1540. Review.

12.

Diagnosis and Management of Hypothyroidism: Addressing the Knowledge-Action Gaps.

Kalra S, Das AK, Bajaj S, Saboo B, Khandelwal D, Tiwaskar M, Agarwal N, Gupta P, Sahay R, Aggarwal S, Ghosh S, Negalur V, Unnikrishnan AG, Bantwal G, Aggarwal R, Chaudhari H, Mulgaonkar N.

Adv Ther. 2018 Oct;35(10):1519-1534. doi: 10.1007/s12325-018-0744-7. Epub 2018 Aug 31. Review.

PMID:
30171491
13.

ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes.

Danne T, Phillip M, Buckingham BA, Jarosz-Chobot P, Saboo B, Urakami T, Battelino T, Hanas R, Codner E.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:115-135. doi: 10.1111/pedi.12718. No abstract available.

PMID:
29999222
14.

The law of investigative parsimony.

Kalra S, Saboo B.

J Pak Med Assoc. 2018 May;68(5):817-818.

15.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

16.

Current Indicators of Nutritional Care in Children with Type 1 Diabetes in India: Do we Need a National Nutritional Guideline?

Kalra S, Das AK, Raghupathy P, Chowdhury S, Saboo BD, Dinakaran P, Chugh S.

Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):670-678. doi: 10.4103/ijem.IJEM_183_17.

17.

Indian College of Physicians Position Statement: Addictive Disorders Among Persons with Diabetes Mellitus.

Balhara YPS, Kalra S, Kuppili PP, Kalaiselvan V, Unnikrishnan AG, Tiwaskar M, Sharma PK, Sahay M, Sahay R, Saboo B, Nadkar MY, Muruganathan A, Khandelwal D, Jeloka T, Ghosh S, Dhorepatil B, Dhamija P, Das AK, Bantwal G, Badani R.

J Assoc Physicians India. 2017 Oct;65(12):11-12.

PMID:
31556275
18.

Ramadan fasting in diabetes-exercise in problem-solving.

Saboo B.

Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S713-S714. doi: 10.1016/j.dsx.2017.05.003. Epub 2017 Jul 29.

PMID:
28943269
19.

Multiple educational programs improves glycemic control, quality of life with diminishing the impact of diabetes in poorly controlled type 1 diabetics.

Vyas C, Dalal L, Talaviya P, Saboo B.

Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S601-S606. doi: 10.1016/j.dsx.2017.04.011. Epub 2017 Apr 12.

PMID:
28927968
20.

Indian College of Physicians Position Statement on Anemia in Metabolic Syndrome.

Sahay M, Kalra S, Tiwaskar M, Ghosh S, Badani R, Bantwal G, Das AK, Dhorepatil B, Jeloka T, Khandelwal D, Nadkar MY, Saboo B, Sahay R, Unnikrishnan AG, Aggarwal S, Agrawal N, Bajaj S, Baruah MP, Chadha M, Das S, Dhamija P, Julka S, Mehta P, Shah SN, Sharma B, Muruganathan A.

J Assoc Physicians India. 2017 Jun;65(6):60-73. No abstract available.

PMID:
28782315
21.

Medication Counseling for Thyroxine.

Kalra S, Unnikrishnan AG, Tiwaskar M, Sahay R, Saboo B, Negalur V, Khandelwal D, Gupta P, Ghosh S, Das AK, Bantwal G, Bajaj S, Agarwal S, Aggarwal R, Agarwal N.

Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):630-631. doi: 10.4103/ijem.IJEM_91_17.

22.

Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017.

Tandon N, Kalra S, Balhara YPS, Baruah MP, Chadha M, Chandalia HB, Prasanna Kumar KM, Madhu SV, Mithal A, Sahay R, Shukla R, Sundaram A, Unnikrishnan AG, Saboo B, Gupta V, Chowdhury S, Kesavadev J, Wangnoo SK.

Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):600-617. doi: 10.4103/ijem.IJEM_97_17. Review.

23.

Clinical practice points for diabetes management during RAMADAN fast.

Sadikot S, Jothydev K, Zargar AH, Ahmad J, Arvind SR, Saboo B.

Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S811-S819. doi: 10.1016/j.dsx.2017.06.003. Epub 2017 Jun 13. Review.

PMID:
28629656
24.

Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.

Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A, John M, Luaia R, Reang T, Ningombam S, Jampa L, Budnah RO, Elangovan N, Subashini R, Venkatesan U, Unnikrishnan R, Das AK, Madhu SV, Ali MK, Pandey A, Dhaliwal RS, Kaur T, Swaminathan S, Mohan V; ICMR–INDIAB Collaborative Study Group.

Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. doi: 10.1016/S2213-8587(17)30174-2. Epub 2017 Jun 7. Erratum in: Lancet Diabetes Endocrinol. 2017 Aug;5(8):e5.

PMID:
28601585
25.

Patient-centered Management of Hypothyroidism.

Kalra S, Agarwal N, Aggarwal R, Agarwal S, Bajaj S, Bantwal G, Das AK, Ghosh S, Gupta P, Khandelwal D, Negalur V, Saboo B, Sahay R, Tiwaskar M, Unnikrishnan AG.

Indian J Endocrinol Metab. 2017 May-Jun;21(3):475-477. doi: 10.4103/ijem.IJEM_93_17.

26.

Diabetes and Anemia: International Diabetes Federation (IDF) - Southeast Asian Region (SEAR) position statement.

Sahay M, Kalra S, Badani R, Bantwal G, Bhoraskar A, Das AK, Dhorepatil B, Ghosh S, Jeloka T, Khandelwal D, Latif ZA, Nadkar M, Pathan MF, Saboo B, Sahay R, Shimjee S, Shrestha D, Siyan A, Talukdar SH, Tiwaskar M, Unnikrishnan AG.

Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S685-S695. doi: 10.1016/j.dsx.2017.04.026. Epub 2017 Apr 28. Review.

PMID:
28483426
27.

Indian College of Physicians (ICP) Position Statement on Pharmacovigilance.

Dhamija P, Kalra S, Sharma PK, Kalaiselvan V, Muruganathan A, Balhara YPS, Badani R, Bantwal G, Das AK, Dhorepatil B, Ghosh S, Jeloka T, Khandelwal D, Nadkar MY, Patnaik KP, Saboo B, Sahay M, Sahay R, Tiwaskar M, Unnikrishnan AG.

J Assoc Physicians India. 2017 Mar;65(3):63-66.

PMID:
28462545
28.

Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.

Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A, Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S507-S521. doi: 10.1016/j.dsx.2017.03.045. Epub 2017 Apr 5. Review.

PMID:
28433618
29.

Consensus recommendations on exploring effective solutions for the rising cost of diabetes.

Sadikot SM, Das AK, Wilding J, Siyan A, Zargar AH, Saboo B, Aravind SR, Sosale B, Kalra S, Vijayakumar G, Manojan KK, Maheshwari A, Panda JK, Banerjee S, Chawla R, Vasudevan SP, Sundar OSS, Kesavadev J.

Diabetes Metab Syndr. 2017 Apr - Jun;11(2):141-147. doi: 10.1016/j.dsx.2017.03.002. Epub 2017 Mar 7. Review.

PMID:
28325543
30.

Indian Injection Technique Study: Population Characteristics and Injection Practices.

Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, Ghosh S, Sanyal D, Hirsch LJ, Gupta V, Strauss KW.

Diabetes Ther. 2017 Jun;8(3):637-657. doi: 10.1007/s13300-017-0243-x. Epub 2017 Mar 13.

31.

Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

Kalra S, Mithal A, Sahay R, John M, Unnikrishnan AG, Saboo B, Ghosh S, Sanyal D, Hirsch LJ, Gupta V, Strauss KW.

Diabetes Ther. 2017 Jun;8(3):659-672. doi: 10.1007/s13300-017-0244-9. Epub 2017 Mar 13.

32.

The rule of two-thirds in diabetes epidemiology.

Kalra S, Saboo B, Sahay R, Khandelwal D, Talwar V, Unnikrishnan AG.

Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):242-244. doi: 10.4103/2230-8210.196027.

33.

Glycemic management during Jain fasts.

Julka S, Sachan A, Bajaj S, Sahay R, Chawla R, Agrawal N, Saboo B, Unnikrishnan AG, Baruah MP, Parmar G, Kalra S.

Indian J Endocrinol Metab. 2017 Jan-Feb;21(1):238-241. doi: 10.4103/2230-8210.192489. Review.

34.

Unproven Therapies for Diabetes and Their Implications.

Kesavadev J, Saboo B, Sadikot S, Das AK, Joshi S, Chawla R, Thacker H, Shankar A, Ramachandran L, Kalra S.

Adv Ther. 2017 Jan;34(1):60-77. doi: 10.1007/s12325-016-0439-x. Epub 2016 Nov 18. Review.

35.

Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India.

Mohan V, Jain S, Kesavadev J, Chawla M, Mutha A, Viswanathan V, Saboo B, Kovil R, Mithal A, Punatar D, Shin J.

J Assoc Physicians India. 2016 Apr;64(4):16-21.

PMID:
27734636
36.

Consensus Statement on Management of Post-Prandial Hyperglycemia in Clinical Practice in India.

Aravind S, Saboo B, Sadikot S, Shah SN, Makkar B, Kalra S, Kannampilly J, Kesavadev J, Ghoshal S, Zargar A, Nigam A, Hazra D, Tripathi K, Dharmalingam M, Shah P, Gandhi P, Sahay R, Unnikrishnan R, Gupta S, Bajaj S, Mukhopadhyay S, Kale S.

J Assoc Physicians India. 2015 Aug;63(8):45-58.

PMID:
27604435
37.

Replication of genome-wide association signals in Asian Indians with early-onset type 2 diabetes.

Chidambaram M, Liju S, Saboo B, Sathyavani K, Viswanathan V, Pankratz N, Gross M, Mohan V, Radha V.

Acta Diabetol. 2016 Dec;53(6):915-923. doi: 10.1007/s00592-016-0889-2. Epub 2016 Aug 4.

PMID:
27488727
38.

Evaluation Series on Safety and Efficacy of Nutritional Supplements in Newly Diagnosed Hyperglycemia: A Placebo-Controlled, Randomized Study.

Thacker H, Bantwal G, Jain S, Kalra S, Kale S, Saboo B, Gupta JB, Sivam S.

N Am J Med Sci. 2016 Feb;8(2):106-13. doi: 10.4103/1947-2714.177320.

39.

Management of anemia in patients with diabetic kidney disease: A consensus statement.

Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta SS, Das A, Chandrasekaran S, Krishnan PV, Shah A, Abraham G, Tikku P, Kumar S.

Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):268-81. doi: 10.4103/2230-8210.176348. Review.

40.

Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2.

Sosale B, Sosale AR, Mohan AR, Kumar PM, Saboo B, Kandula S.

Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):114-8. doi: 10.4103/2230-8210.172277.

41.

Retrospective comparison of voglibose or acarbose as an add-on therapy to sulfonylureas in Western Indian patients with uncontrolled overweight/obese type 2 diabetes.

Talaviya PA, Saboo BD, Dodiya HG, Rao SK, Joshi SR, Modh VB, Ghadiya SV.

Diabetes Metab Syndr. 2016 Apr-Jun;10(2):88-91. doi: 10.1016/j.dsx.2015.09.021. Epub 2015 Nov 25.

PMID:
26777258
42.

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy.

Kesavadev J, Saboo B, Shankar A, Krishnan G, Jothydev S.

Indian J Endocrinol Metab. 2015 Nov-Dec;19(6):764-9. doi: 10.4103/2230-8210.167560. Review.

43.

CSII as an Alternative Therapeutic Strategy for Managing Type 2 Diabetes: Adding the Indian Experience to a Global Perspective.

Kesavadev J, Shankar A, Sadasrian Pillai PB, Saboo B, Joshi S, Krishnan G, Jothydev S.

Curr Diabetes Rev. 2016;12(4):312-314. Review.

PMID:
26643928
44.

Review of Clinical Profile of IDegAsp.

Unnikrishnan AG, Singh AK, Modi KD, Saboo B, Garcha SC, Rao PV.

J Assoc Physicians India. 2015 May;63(5 Suppl):15-20. Review.

PMID:
26548030
45.

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.

Gupta S, Gupta K, Ravi R, Mehta V, Banerjee S, Joshi S, Saboo B.

Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):639-43. doi: 10.4103/2230-8210.163187.

46.

Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study.

Gupta R, Sharma KK, Gupta BK, Gupta A, Saboo B, Maheshwari A, Mahanta T, Deedwania PC.

J Glob Health. 2015 Jun;5(1):010411. doi: 10.7189/jogh.05.010411.

47.

Type 1 diabetes: Awareness, management and challenges: Current scenario in India.

Kumar KM, Saboo B, Rao PV, Sarda A, Viswanathan V, Kalra S, Sethi B, Shah N, Srikanta SS, Jain SM, Raghupathy P, Shukla R, Jhingan A, Chowdhury S, Jabbar PK, Kanungo A, Joshi R, Kumar S, Tandon N, Khadilkar V, Chadha M.

Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1):S6-8. doi: 10.4103/2230-8210.155339.

48.

Key elements of successful intensive therapy in patients with type 1 diabetes.

Saboo B.

Indian J Endocrinol Metab. 2015 Apr;19(Suppl 1):S44-6. doi: 10.4103/2230-8210.155395.

49.

Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R.

J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 6. Review.

50.

Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence.

Sosale A, Saboo B, Sosale B.

Diabetes Metab Syndr Obes. 2015 Apr 15;8:189-96. doi: 10.2147/DMSO.S49592. eCollection 2015. Review.

Supplemental Content

Support Center